ANAHEIM, Calif., April 7, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share ($1.20 per share on an annual basis). The dividend will be paid on or about July 8, 2014 to shareholders of record at the close of business on July 1, 2014. The Company previously announced the declaration of a quarterly cash dividend of $0.30 per share which will be paid on or about April 25, 2014 to shareholders of record at the close of business on April 18, 2014.
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor also provides specialty contract manufacturing services to the global pharmaceutical industry through its wholly-owned subsidiary BioVectra Inc. For more information about Questcor, please visit www.questcor.com
SOURCE Questcor Pharmaceuticals, Inc.